4//SEC Filing
O'Leary James J 4
Accession 0000899243-21-005317
CIK 0001805890other
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 9:01 PM ET
Size
9.9 KB
Accession
0000899243-21-005317
Insider Transaction Report
Form 4
O'Leary James J
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-02-04+114,000→ 114,000 totalExercise: $11.90Exp: 2031-02-03→ Common Stock (114,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to this option shall vest and become exercisable on February 4, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter.
Issuer
Fusion Pharmaceuticals Inc.
CIK 0001805890
Entity typeother
Related Parties
1- filerCIK 0001449753
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 9:01 PM ET
- Size
- 9.9 KB